Clinical Trials
335 trialsdOCT-pBCC
Vejle Hospital
Vaccination With Flt3L, Radiation, and Poly-ICLC
Icahn School of Medicine at Mount Sinai
CUPem
Imperial College London
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BEATcc
Grupo Español de Investigación en Cáncer de Ovario
TraveraRTGx
Travera Inc
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Merck Sharp & Dohme LLC
KEYLYNK-008
Merck Sharp & Dohme LLC
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Boehringer Ingelheim
PESTIPAC
CHU de Reims
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
FORTIFY
Akamis Bio
ORPHYS
Universitätsklinikum Hamburg-Eppendorf
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
Adaptimmune
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings
UNC Lineberger Comprehensive Cancer Center
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Jemincare
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
Hookipa Biotech GmbH
VITAL
Sanofi
Skippy 1
Leiden University Medical Center
MEK162
University Health Network, Toronto
Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.
Centre Hospitalier Universitaire de Saint Etienne
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
University of California, San Diego
SMART ONE
Baptist Health South Florida
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Verrica Pharmaceuticals Inc.
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Pfizer
ARROW
Hoffmann-La Roche
Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO
National Cancer Centre, Singapore
Existential Distress in Patients with Advanced Cancer and Their Caregivers
Universitätsklinikum Hamburg-Eppendorf
STAR
Akamis Bio
NEBULA
Akamis Bio
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
DWI-PDAC
Laval University
Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
HiberCell, Inc.
Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer
Sichuan University
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
IT-01
Intensity Therapeutics, Inc.
MAApping
Sirtex Medical
KEYNOTE-B84
Vaccinex Inc.
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
University of California, San Diego
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
Helsinki University Central Hospital
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
M.D. Anderson Cancer Center
A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer
BeiGene
STAR-TOR
Pfizer
Smartphone App for Cancer Medication Adherence
Columbia University
Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management
Changsha Medical University